Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheim...
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
About this item
Full title
Author / Creator
Ahmad, Shahzad , Orellana, Adelina , Kohler, Isabelle , Frölich, Lutz , de Rojas, Itziar , Gil, Silvia , Boada, Mercè , Hernández, Isabel , Hausner, Lucrezia , Bakker, Margot H. M , Cabrera-Socorro, Alfredo , Amin, Najaf , Ramírez, Alfredo , Ruiz, Agustín , Hankemeier, Thomas and Van Duijn, Cornelia M
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Lysophosphatidic acids (LPAs) are bioactive signaling phospholipids that have been implicated in Alzheimer's disease (AD). It is largely unknown whether LPAs are associated with AD pathology and progression from mild cognitive impairment (MCI) to AD. Methods The current study was performed on cerebrospinal fluid (CSF) and plasma samples...
Alternative Titles
Full title
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ac7c9027ac5f4c9bbafbd9c37495b270
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac7c9027ac5f4c9bbafbd9c37495b270
Other Identifiers
ISSN
1758-9193
E-ISSN
1758-9193
DOI
10.1186/s13195-020-00680-9
